Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NEUTROFLOW: Development and Validation of a Pan-cancer Neutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis of Blood Samples

NCT07246759 is registered in ClinicalTrials.gov with OncoHost Ltd. as lead sponsor.

NCT NCT07246759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07246759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NEUTROFLOW: Development and Validation of a Pan-cancer Neutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis of Blood Samples
Lead sponsor
OncoHost Ltd.
Phase
Observational
Overall status
Not yet recruiting
Start date
November 15, 2025
Completion date
May 30, 2028
Enrollment
600 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hnscc, melanoma (skin cancer), non small cell lung cancer (nsclc), rcc, renal cell cancer, triple negative breast cancer (tnbc)